Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A West Virginia woman is suing Bayer Pharmaceuticals for the injuries she allegedly sustained from the oral contraceptive pill Yaz. Karen Hartlove alleges that as a direct result of using the medication she suffered multiple blood clot injuries and is still contending with the lasting effects.
Hartlove had been prescribed Yaz for birth control. Soon after starting the medication she developed a number of side effects, which eventually led to the discovery of Yaz blood clots, her lawsuit says.
After her examination, doctors diagnosed Hartlove in October 2009 with deep vein thrombosis. That led to regular doctor’s visits and medical monitoring. Hartlove filed the Yaz blood clot lawsuit after learning that Yaz and its related drugs, Ocella and Yasmin, were directly linked to blood clot injuries, through U.S. Food and Drug Administration announcements and television commercials.
Hartlove states in the Yaz lawsuit that Bayer should have warned her and her physician about this possibility, and asserts that if she had known about this risk she never would have taken the medication. Hartlove insists that Bayer had the responsibility to warn her and other patients.
The Yaz birth control lawsuit against Bayer Pharmaceuticals alleges negligence, false advertising, concealing information, and misrepresenting a product.
Overview of Yaz Blood Clot Complications
Yaz was first approved for market in 2006 by the FDA to be used an oral contraceptive and to treat mild acne. Along with its older brother, Yasmin, and its generic cousin, Ocella, it is a combination oral contraceptive (COC), which is birth control that contains both an estrogen and progestin component. Yaz is currently one of the most popularly prescribed oral contraceptives in the United States, with millions of users. However, Yaz and its relatives are under fire for the alleged connection with blood-clot injuries. Many experts suspect that the drug’s progestin component, drospirenone, is to blame for the injuries.
Because drospirenone was only recently developed, there is not much scientific data available; leading many medical experts to question whether enough enough is known about the drug to determine it be safe. One known side effect of drospirenone is that it is a diuretic, which means it raises the potassium levels of the blood. This causes the blood-flow to slow down, which allows for the possibility of the formation of blood clots, pulmonary embolism, deep vein thrombosis, and other similar injuries.
The FDA announced that from 2004 to 2008, there had been more than 50 deaths among users of Yaz, Yasmin, and Ocella. The cause of these deaths included: cardiac arrhythmia, cardiac arrest, intracardiac thrombus, pulmonary embolism, and stroke. All of these were women in their child bearing years, with one of the victims being as young as 17.
Despite this, and other scientific evidence, the current Yaz warning label does not include an indication for blood clot injuries.
Get a Free Birth Control Blood Clot Compensation Review
If you believe that you or a loved one have been the victim of a birth control blood clot injury, you have legal options. See if you qualify for compensation by submitting your information for a free and confidential case evaluation:
Oops! We could not locate your form.
Â
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.